Peer Review reports
From: CAR-T cells targeting CD38 and LMP1 exhibit robust antitumour activity against NK/T cell lymphoma
| Original Submission | ||
|---|---|---|
| 14 Apr 2023 | Submitted | Original manuscript |
| 11 May 2023 | Author responded | Author comments - Hongwen Li |
| Resubmission - Version 2 | ||
| 11 May 2023 | Submitted | Manuscript version 2 |
| 16 May 2023 | Reviewed | Reviewer Report |
| 2 Jun 2023 | Reviewed | Reviewer Report |
| 21 Jun 2023 | Reviewed | Reviewer Report |
| 4 Jul 2023 | Author responded | Author comments - Hongwen Li |
| Resubmission - Version 3 | ||
| 4 Jul 2023 | Submitted | Manuscript version 3 |
| 8 Jul 2023 | Reviewed | Reviewer Report |
| 12 Jul 2023 | Reviewed | Reviewer Report |
| 21 Jul 2023 | Author responded | Author comments - Hongwen Li |
| Resubmission - Version 4 | ||
| 21 Jul 2023 | Submitted | Manuscript version 4 |
| 27 Jul 2023 | Reviewed | Reviewer Report |
| 9 Aug 2023 | Author responded | Author comments - Hongwen Li |
| Resubmission - Version 5 | ||
| 9 Aug 2023 | Submitted | Manuscript version 5 |
| 17 Aug 2023 | Author responded | Author comments - Hongwen Li |
| Resubmission - Version 6 | ||
| 17 Aug 2023 | Submitted | Manuscript version 6 |
| Publishing | ||
| 18 Aug 2023 | Editorially accepted | |
| 30 Aug 2023 | Article published | 10.1186/s12916-023-03040-0 |
You can find further information about peer review here.